ARCHIVES

Bristol-Myers, Karolinska In Collaboration For Studies.

This article is from The Cancer Letter archive.

Vol. 26 No. 13 | March 31, 2000

Download PDF Visit The Full Archive

Related Articles

MET Inhibitor Improved Time To Progression by 56 Percent

June 29, 2012

Study: Drug Discounts Used For Wealthier Patients In Many 340B-Enrolled Hospitals

October 10, 2014

Herceptin With Adjuvant Chemo Improves Disease-Free Survival, Phase III Trial Finds

January 29, 2010

Also Stillman named director, Cold Spring Harbor, Watson is chancellor.

December 12, 2003

DRCCA’s New Board Of Scientific Counselors to Meet Sept. 18-19

August 22, 1980

Missouri Center Director Search Narrowed To Vincent, Wiernik

September 10, 1982